Interview 27 Sep 2022 Natural killer cells: a thriving frontier in allogeneic cell therapy …highest dose responded to the treatment. “By bringing it in closer proximity to the target with this engaging molecule, they had a great response,” said Pinkernell. “I think that opens… September 27, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2018 Could Stem Cells Replace Animal Testing in Drug Development? …that don’t come with the moral dilemma? There are indeed alternatives, but they may not be obvious. One of the alternatives are stem cells. While a lot of attention to… May 14, 2018 - 6 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2021 European Cancer Deals Increasingly Focus on Natural Killer Cells …Cellectis and US company Cytovia. T-cell immunotherapies like CAR T-cell therapy have revolutionized cancer treatment in recent times. However, they have a significant disadvantage. The patient needs to get their… February 23, 2021 - 6 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
In Depth 11 Oct 2021 A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology …are many, and the technology is clearly not perfect yet, but CAR-T cells offer hope for patients that had none before. With the first therapies already on the market, the… October 11, 2021 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 …cancer treatment,” said Schoenfeld. CAR-T for cancer in 2025: need to overcome toxicities Besides, we can’t talk about cancer immunotherapies without getting into chimeric antigen receptor (CAR)-T therapies. The T… February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 11 Aug 2020 How European Startups Have Advanced Cancer T-Cell Therapy in 2020 …system, T-knife then expresses them in the patient’s T cells to produce the cell therapy. “The mouse immune system is not tolerant of human tumor antigens – it sees them… August 11, 2020 - 8 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2025 The stem cell race for Parkinson’s disease: Recent studies show significant promise …that stem cells can be implanted into the brain to take the place of the cells that have been lost – a potentially transformative treatment approach for Parkinson’s. Although the… May 14, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Feb 2025 The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells …over the last few decades to transplant animal cells, tissues, and organs into humans, the advent of new gene editing techniques like CRISPR has brought xenotransplantation back into the spotlight…. February 21, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023 The next breakthrough in cancer treatment? …cells. This is a type of immune cell that specializes in killing cancer cells. These cells may be of great importance for cancer treatment in the future. NK cells kill… January 31, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Nov 2025 Swiss biotech going strong in 2025: 19 companies to put on your radar …libraries to discover binders and assemble modular TCEs that redirect T cells to tumor cells while sparing healthy tissue; the company also applies the same technology to precisely target disease-driving… November 12, 2025 - 20 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Aug 2022 Potential new treatment for angioimmunoblastic T-cell lymphoma? …cells, accumulate mutations in genes that control how the genetic material in the cell is packaged. These aberrant B cells then interact with T cells and lead to the development… August 24, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2022 FMRP – the protein behind immunotherapy resistance …by the observation that wild-type tumors had very few infiltrating T lymphocytes, whereas knockout tumors were highly inflamed. Depleting T cells from the FMRP-knockout tumors caused them to start growing… November 21, 2022 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email